Indegene Ltd. News and Updates

Name: Latest research reports of Indegene Ltd. authored by KRChoksey and published by - Trendlyne research reports.
Item: Indegene Ltd.
Rating: 5
Author: KRChoksey

Keep track of all breaking news on Indegene Ltd. from all sources in a single place.

Load latest

Indegene Ltd.

06 May 2024

552.05

4.40%

IPO Note

IPO Subscribe: Indegene Ltd.

KRChoksey

Indegene provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products. The Company has established client relationships with each of the 20 largest biopharmaceutical companies in the world.

Indegene Ltd. has an average target of 660.00 from 7 brokers.

Indegene Ltd.

03 May 2024

552.05

4.40%

IPO Note - Indegene Limited 06052024

IPO Note: Indegene Ltd.

HDFC Securities

IPO Note - Indegene Limited Indegene Limited (IL) provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech and medical devices companies, that assist them with drug development and clinical trials, regulatory submissions, pharmacovigilance and complaints management, and the sales and marketing of their products